EI
CTKB icon

Ellevest Inc’s Cytek Biosciences CTKB Stock Holding History

Ellevest Inc’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-68
Closed -$625 – 642
2023
Q1 		$625 Sell
68
-21
-24% -$226 ﹤0.01% 1648
2022
Q4 		$909 Sell
89
-23
-21% -$309 ﹤0.01% 1541
2022
Q3 		$2K Hold
112
– – ﹤0.01% 1327
2022
Q2 		$1K Buy
+112
New +$1.11K ﹤0.01% 1233

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ellevest Inc's CTKB Position: Q2 2023 in Review

Ellevest Inc sold out of Cytek Biosciences (CTKB) in Q2 2023, closing a stake of 68 shares — an estimated $625 sold.

Ellevest Inc first reported a position in CTKB in Q2 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 101 funds tracked by Wall St. Rank hold CTKB as of Q2 2023.

  • Ellevest Inc reported no remaining Cytek Biosciences position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 68 Cytek Biosciences shares in Q2 2023, an estimated $625.
  • Ellevest Inc first reported a position in Cytek Biosciences in Q2 2022 and held it in 4 quarters.
  • Ellevest Inc's Cytek Biosciences position peaked at $2K in Q3 2022.
  • 101 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.